Amphastar Pharmaceuticals, Inc. (AMPH) — SC 13G/A Filings
All SC 13G/A filings from Amphastar Pharmaceuticals, Inc.. Browse 5 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (5)
- SC 13G/A Filing — Mar 6, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Amphastar Insider Jack Zhang Updates Holdings; Maintains Significant Stake
— Feb 9, 2024 Risk: low
Jack Yongfeng Zhang, a key insider at Amphastar Pharmaceuticals, Inc., has filed an amendment (SC 13G/A) indicating a change in his beneficial ownership as of D -
BlackRock Amends Amphastar Pharma Stake (SC 13G/A)
— Jan 23, 2024
BlackRock, Inc. filed an amended SC 13G/A on January 23, 2024, indicating a change in its ownership stake in Amphastar Pharmaceuticals, Inc. as of December 31, -
Federated Hermes Amends Amphastar Pharma Stake as of Dec 31, 2023
— Jan 17, 2024
Federated Hermes, Inc. filed an amended SC 13G/A on January 17, 2024, disclosing its ownership of Amphastar Pharmaceuticals, Inc. common stock as of December 31
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX